Repligen Corp. (RGEN)
175.42
-8.75
(-4.75%)
USD |
NASDAQ |
Oct 16, 16:00
175.43
+0.01
(+0.01%)
After-Hours: 20:00
Repligen Cash from Investing (Quarterly) : -2.089M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.089M |
| March 31, 2026 | -3.988M |
| December 31, 2025 | -208.74M |
| September 30, 2025 | -7.783M |
| June 30, 2025 | -7.839M |
| March 31, 2025 | -74.11M |
| December 31, 2024 | -64.76M |
| September 30, 2024 | -5.859M |
| June 30, 2024 | -7.40M |
| March 31, 2024 | -8.362M |
| December 31, 2023 | -169.90M |
| September 30, 2023 | -8.77M |
| June 30, 2023 | 64.83M |
| March 31, 2023 | -9.433M |
| December 31, 2022 | -121.31M |
| September 30, 2022 | -57.49M |
| June 30, 2022 | -26.22M |
| March 31, 2022 | -28.21M |
| December 31, 2021 | -62.28M |
| September 30, 2021 | -132.70M |
| June 30, 2021 | -17.20M |
| March 31, 2021 | -8.997M |
| December 31, 2020 | -158.29M |
| September 30, 2020 | -33.58M |
| June 30, 2020 | -4.48M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.037M |
| December 31, 2019 | -7.111M |
| September 30, 2019 | -6.892M |
| June 30, 2019 | -187.48M |
| March 31, 2019 | -3.828M |
| December 31, 2018 | -5.457M |
| September 30, 2018 | -4.168M |
| June 30, 2018 | -2.848M |
| March 31, 2018 | -1.564M |
| December 31, 2017 | -1.171M |
| September 30, 2017 | -111.21M |
| June 30, 2017 | 8.055M |
| March 31, 2017 | 6.077M |
| December 31, 2016 | -35.32M |
| September 30, 2016 | -13.90M |
| June 30, 2016 | -1.18M |
| March 31, 2016 | 1.20M |
| December 31, 2015 | 2.672M |
| September 30, 2015 | 1.616M |
| June 30, 2015 | 0.2239M |
| March 31, 2015 | 0.2792M |
| December 31, 2014 | -1.223M |
| September 30, 2014 | -1.716M |
| June 30, 2014 | -17.81M |
| March 31, 2014 | 0.9616M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioLife Solutions, Inc. (DELISTED) | -1.579M |
| Anika Therapeutics, Inc. | -1.28M |
| Danaher Corp. | -10.15B |
| Precigen, Inc. | 26.69M |
| Liquidia Corp. | -12.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 32.77M |
| Cash from Financing (Quarterly) | -6.20M |
| Free Cash Flow | 110.15M |
| Free Cash Flow Per Share (Quarterly) | 0.4714 |
| Free Cash Flow to Equity (Quarterly) | 23.38M |
| Free Cash Flow to Firm (Quarterly) | 28.85M |
| Free Cash Flow Yield | 1.11% |